A Preliminary Trial Of Serratiopeptidase In Patients With Carpal Tunnel Syndrome
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 男女 |
| 年齢 | 30-44, 45-64 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of serrapeptase (20mg) daily after an initial course of nimesulide was able to reduce symptoms of carpal tunnel syndrome in 65% of patients studied, but this trial failed to have a placebo group (and even then, is confounded by the initial course of nimesulide).